1036897-66-1

Basic information

• Product Name: (2,2-Dimethoxy-ethyl)-[1-(4-fluoro-phenyl)-meth-(E)-ylidene]-amine
• Synonyms: (2,2-Dimethoxy-ethyl)-[1-(4-fluoro-phenyl)-meth-(E)-ylidene]-amine
• CAS NO: 1036897-66-1
• Molecular Weight: 211.236
• Mol File: 1036897-66-1.mol

Chemical Properties

• CAS DataBase Reference: (2,2-Dimethoxy-ethyl)-[1-(4-fluoro-phenyl)-meth-(E)-ylidene]-amine(CAS DataBase Reference)
• NIST Chemistry Reference: (2,2-Dimethoxy-ethyl)-[1-(4-fluoro-phenyl)-meth-(E)-ylidene]-amine(1036897-66-1)
• EPA Substance Registry System: (2,2-Dimethoxy-ethyl)-[1-(4-fluoro-phenyl)-meth-(E)-ylidene]-amine(1036897-66-1)

Safety Data

• Hazardous Substances Data: 1036897-66-1(Hazardous Substances Data)

Upstream product

• 459-57-4 4-fluorobenzaldehyde 
• 22483-09-6 2,2-dimethoxyethylamine 

Downstream Products

• 95333-74-7 1-(4-Fluoro-benzyl)-1,3-dihydro-imidazole-2-thione 

Relevant articles and documents

CYCLOALKYLAMINE SUBSTITUTED ISOQUINOLONE DERIVATIVES

The invention relates to 6-substituted isoquinolone derivatives of the formula (I) useful for the treatment and/or prevention of diseases associated with Rho-kinase and/or Rho-kinase mediated phosphorylation of myosin light chain phosphatase, and composit

CYCLOALKYLAMINE SUBSTITUTED ISOQUINOLINE DERIVATIVES

The invention relates to 6-substituted isoquinoline derivatives of the Formula (I) useful for the treatment and/or prevention of diseases associated with Rho-kinase and/or Rho-kinase mediated phosphorylation of myosin light chain phosphatase, and compositions containing such compounds.

CYCLOALKYLAMINE SUBSTITUTED ISOQUINOLINE AND ISOQUINOLINONE DERIVATIVES

The invention relates to 6-substituted isoquinoline and isoquinolinone derivatives of the formula (I) useful for the treatment and/or prevention of diseases associated with Rho-kinase and/or Rho-kinase mediated phosphorylation of myosin light chain phosphatase, and compositions containing such compounds.

ISOQUINOLINE DERIVATIVES AS INHIBITORS OF RHO-KINASE

The invention relates to 6-piperidinyl-substituted isoquinoline derivatives of the formula (I); useful for the treatment and/or prevention of diseases associated with Rho-kinase and/or Rho-kinase mediated phosphorylation of myosin light chain phosphatase, and compositions containing such compounds.